These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

673 related items for PubMed ID: 22824293

  • 1. Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models.
    Gupta P, Srivastava SK.
    BMC Med; 2012 Jul 24; 10():80. PubMed ID: 22824293
    [Abstract] [Full Text] [Related]

  • 2. Bim contributes to phenethyl isothiocyanate-induced apoptosis in breast cancer cells.
    Hahm ER, Singh SV.
    Mol Carcinog; 2012 Jun 24; 51(6):465-74. PubMed ID: 21739479
    [Abstract] [Full Text] [Related]

  • 3. Phenethyl isothiocyanate hampers growth and progression of HER2-positive breast and ovarian carcinoma by targeting their stem cell compartment.
    Koschorke A, Faraci S, Giani D, Chiodoni C, Iorio E, Canese R, Colombo MP, Lamolinara A, Iezzi M, Ladomery M, Vernieri C, de Braud F, Di Nicola M, Tagliabue E, Castagnoli L, Pupa SM.
    Cell Oncol (Dordr); 2019 Dec 24; 42(6):815-828. PubMed ID: 31376137
    [Abstract] [Full Text] [Related]

  • 4. Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain.
    Gril B, Palmieri D, Bronder JL, Herring JM, Vega-Valle E, Feigenbaum L, Liewehr DJ, Steinberg SM, Merino MJ, Rubin SD, Steeg PS.
    J Natl Cancer Inst; 2008 Aug 06; 100(15):1092-103. PubMed ID: 18664652
    [Abstract] [Full Text] [Related]

  • 5. Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene.
    Menendez JA, Vellon L, Lupu R.
    Ann Oncol; 2005 Aug 06; 16(8):1253-67. PubMed ID: 15870086
    [Abstract] [Full Text] [Related]

  • 6. Quercetin induces caspase-dependent extrinsic apoptosis through inhibition of signal transducer and activator of transcription 3 signaling in HER2-overexpressing BT-474 breast cancer cells.
    Seo HS, Ku JM, Choi HS, Choi YK, Woo JK, Kim M, Kim I, Na CH, Hur H, Jang BH, Shin YC, Ko SG.
    Oncol Rep; 2016 Jul 06; 36(1):31-42. PubMed ID: 27175602
    [Abstract] [Full Text] [Related]

  • 7. HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib.
    Valabrega G, Capellero S, Cavalloni G, Zaccarello G, Petrelli A, Migliardi G, Milani A, Peraldo-Neia C, Gammaitoni L, Sapino A, Pecchioni C, Moggio A, Giordano S, Aglietta M, Montemurro F.
    Breast Cancer Res Treat; 2011 Nov 06; 130(1):29-40. PubMed ID: 21153051
    [Abstract] [Full Text] [Related]

  • 8. Development of the CK-MB-1 trastuzumab-resistant HER2-positive breast cancer cell line and xenograft animal models.
    Chung WP, Huang WL, Liao WA, Huang WL, Liu YY, Su WC.
    Cancer Med; 2021 Apr 06; 10(7):2370-2379. PubMed ID: 33665980
    [Abstract] [Full Text] [Related]

  • 9. PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.
    Park SH, Ito K, Olcott W, Katsyv I, Halstead-Nussloch G, Irie HY.
    Breast Cancer Res; 2015 Jun 19; 17(1):86. PubMed ID: 26084280
    [Abstract] [Full Text] [Related]

  • 10. Poly (ADP-ribose) polymerase inhibition enhances trastuzumab antitumour activity in HER2 overexpressing breast cancer.
    García-Parra J, Dalmases A, Morancho B, Arpí O, Menendez S, Sabbaghi M, Zazo S, Chamizo C, Madoz J, Eroles P, Servitja S, Tusquets I, Yelamos J, Lluch A, Arribas J, Rojo F, Rovira A, Albanell J.
    Eur J Cancer; 2014 Oct 19; 50(15):2725-34. PubMed ID: 25128455
    [Abstract] [Full Text] [Related]

  • 11. 64Cu-Labeled Trastuzumab Fab-PEG24-EGF Radioimmunoconjugates Bispecific for HER2 and EGFR: Pharmacokinetics, Biodistribution, and Tumor Imaging by PET in Comparison to Monospecific Agents.
    Kwon LY, Scollard DA, Reilly RM.
    Mol Pharm; 2017 Feb 06; 14(2):492-501. PubMed ID: 28049295
    [Abstract] [Full Text] [Related]

  • 12. The novel camptothecin derivative, CPT211, induces cell cycle arrest and apoptosis in models of human breast cancer.
    Chiu CF, Lin YQ, Park JM, Chen YC, Hung SW, Chiu CC, Chang CF.
    Biomed Pharmacother; 2020 Aug 06; 128():110309. PubMed ID: 32505820
    [Abstract] [Full Text] [Related]

  • 13. CIP2A is a target of bortezomib in human triple negative breast cancer cells.
    Tseng LM, Liu CY, Chang KC, Chu PY, Shiau CW, Chen KF.
    Breast Cancer Res; 2012 Apr 26; 14(2):R68. PubMed ID: 22537901
    [Abstract] [Full Text] [Related]

  • 14. Antitumor activity of a monoclonal antibody targeting major histocompatibility complex class I-Her2 peptide complexes.
    Jain R, Rawat A, Verma B, Markiewski MM, Weidanz JA.
    J Natl Cancer Inst; 2013 Feb 06; 105(3):202-18. PubMed ID: 23300219
    [Abstract] [Full Text] [Related]

  • 15. Phenethyl isothiocyanate induced apoptosis via down regulation of Bcl-2/XIAP and triggering of the mitochondrial pathway in MCF-7 cells.
    Lee JW, Cho MK.
    Arch Pharm Res; 2008 Dec 06; 31(12):1604-12. PubMed ID: 19099231
    [Abstract] [Full Text] [Related]

  • 16. Synergy of leptin/STAT3 with HER2 receptor induces tamoxifen resistance in breast cancer cells through regulation of apoptosis-related genes.
    Papanikolaou V, Stefanou N, Dubos S, Papathanasiou I, Palianopoulou M, Valiakou V, Tsezou A.
    Cell Oncol (Dordr); 2015 Apr 06; 38(2):155-64. PubMed ID: 25539992
    [Abstract] [Full Text] [Related]

  • 17. Induction of caspase-dependent extrinsic apoptosis by apigenin through inhibition of signal transducer and activator of transcription 3 (STAT3) signalling in HER2-overexpressing BT-474 breast cancer cells.
    Seo HS, Jo JK, Ku JM, Choi HS, Choi YK, Woo JK, Kim HI, Kang SY, Lee KM, Nam KW, Park N, Jang BH, Shin YC, Ko SG.
    Biosci Rep; 2015 Oct 23; 35(6):. PubMed ID: 26500281
    [Abstract] [Full Text] [Related]

  • 18. STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits.
    Chung SS, Giehl N, Wu Y, Vadgama JV.
    Int J Oncol; 2014 Feb 23; 44(2):403-11. PubMed ID: 24297508
    [Abstract] [Full Text] [Related]

  • 19. Metastasis of Breast Tumor Cells to Brain Is Suppressed by Phenethyl Isothiocyanate in a Novel In Vivo Metastasis Model.
    Gupta P, Adkins C, Lockman P, Srivastava SK.
    PLoS One; 2013 Feb 23; 8(6):e67278. PubMed ID: 23826254
    [Abstract] [Full Text] [Related]

  • 20. Imaging of HER2-Positive Tumors in NOD/SCID Mice with Pertuzumab Fab-Hexahistidine Peptide Immunoconjugates Labeled with [99mTc]-(I)-Tricarbonyl Complex.
    Facca VJ, Al-Saden N, Ku A, Reilly RM.
    Mol Imaging Biol; 2021 Aug 23; 23(4):495-504. PubMed ID: 33479914
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.